Literature DB >> 18309533

The protein kinase Aurora C phosphorylates TRF2.

Daniel Spengler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18309533     DOI: 10.4161/cc.6.20.4781

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

1.  Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2.

Authors:  Jing Zhou; Zhong Deng; Julie Norseen; Paul M Lieberman
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

Review 2.  The Aurora kinase inhibitors in cancer research and therapy.

Authors:  Jonas Cicenas
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-01       Impact factor: 4.553

3.  Aurora kinase-C-T191D is constitutively active mutant.

Authors:  Jabbar Khan; Sanaullah Khan; Sobia Attaullah; Ijaz Ali; Shahid Niaz Khan
Journal:  BMC Cell Biol       Date:  2012-03-26       Impact factor: 4.241

4.  Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.

Authors:  Jabbar Khan; Frédéric Ezan; Jean-Yves Crémet; Alain Fautrel; David Gilot; Marine Lambert; Christelle Benaud; Marie-Bérengère Troadec; Claude Prigent
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

5.  Structural and functional analyses of the mammalian TIN2-TPP1-TRF2 telomeric complex.

Authors:  Chunyi Hu; Rekha Rai; Chenhui Huang; Cayla Broton; Juanjuan Long; Ying Xu; Jing Xue; Ming Lei; Sandy Chang; Yong Chen
Journal:  Cell Res       Date:  2017-11-21       Impact factor: 46.297

6.  Chromatin structure in telomere dynamics.

Authors:  Alessandra Galati; Emanuela Micheli; Stefano Cacchione
Journal:  Front Oncol       Date:  2013-03-07       Impact factor: 6.244

Review 7.  Functions of Aurora kinase C in meiosis and cancer.

Authors:  Suzanne M Quartuccio; Karen Schindler
Journal:  Front Cell Dev Biol       Date:  2015-08-20

Review 8.  A new aurora in anaplastic thyroid cancer therapy.

Authors:  Enke Baldini; Massimino D'Armiento; Salvatore Ulisse
Journal:  Int J Endocrinol       Date:  2014-07-01       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.